208 related articles for article (PubMed ID: 1766538)
1. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
[TBL] [Abstract][Full Text] [Related]
2. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors.
Batabyal SK; Ghosh B; Sengupta S; Ghosh SN; Chatterjee R
Neoplasma; 2003; 50(5):377-9. PubMed ID: 14628092
[TBL] [Abstract][Full Text] [Related]
4. [Myelin basic protein in the cerebrospinal fluid of patients with neurological disease: especially with malignant brain tumors].
Nakagawa H; Fujita T; Tsuruzono K; Kubo S; Yamada M; Miyawaki Y; Tokiyoshi K; Kanayama T; Hasegawa H; Koshino K
No Shinkei Geka; 1994 Feb; 22(2):111-8. PubMed ID: 7509461
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of beta 2-microglobulin and carcinoembryonic antigen in intracranial tumors].
Suzuki Y; Ishii R; Otsuka R; Ogawa Y; Kikuoka M; Hirano K; Tanaka R
No To Shinkei; 1987 Oct; 39(10):965-70. PubMed ID: 3325088
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid biochemical markers of central nervous system metastases.
Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
[TBL] [Abstract][Full Text] [Related]
7. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
[TBL] [Abstract][Full Text] [Related]
8. [A case of leptomeningeal carcinomatosis: demonstration of CA19-9 and CEA positive malignant cells in the CSF and particular elevation of CA19-9 level in the CSF].
Sato Y; Ohta Y; Ohtsuka T; Shoji H; Oizumi K
Rinsho Shinkeigaku; 1991 Feb; 31(2):175-8. PubMed ID: 2060242
[TBL] [Abstract][Full Text] [Related]
9. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
[TBL] [Abstract][Full Text] [Related]
10. The relationship of polyamines in cerebrospinal fluid to the presence of central nervous system tumors.
Marton LJ; Heby O; Levin VA; Lubich WP; Crafts DC; Wilson CB
Cancer Res; 1976 Mar; 36(3):973-7. PubMed ID: 1253185
[TBL] [Abstract][Full Text] [Related]
11. The cytopathology of cerebrospinal fluid. II. Metastatic cancer, meningeal carcinomatosis and primary central nervous system neoplasms.
Bigner SH; Johnston WW
Acta Cytol; 1981; 25(5):461-79. PubMed ID: 7025541
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid polyamines: biochemical markers of malignant childhood brain tumors.
Phillips PC; Kremzner LT; De Vivo DC
Ann Neurol; 1986 Apr; 19(4):360-4. PubMed ID: 3010800
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of sialic acid in the CSF; in relation to the malignancy and leptomeningeal dissemination].
Moroki K; Kuratsu J; Yoshioka S; Kohchi M; Uemura S; Matsukado Y; Ushio Y
No To Shinkei; 1989 Mar; 41(3):305-7. PubMed ID: 2757844
[TBL] [Abstract][Full Text] [Related]
14. [Study of meningeal carcinomatosis: diagnosis and treatment].
Nakagawa H; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Kubo S; Hayakawa T
No Shinkei Geka; 1992 Jan; 20(1):31-7. PubMed ID: 1738424
[TBL] [Abstract][Full Text] [Related]
15. Activity of ornithine decarboxylase (ODC) and polyamine levels as biochemical markers of malignancy in human brain tumors.
Ernestus RI; Röhn G; Schröder R; Klug N; Hossmann KA; Paschen W
Acta Histochem Suppl; 1992; 42():159-64. PubMed ID: 1584960
[TBL] [Abstract][Full Text] [Related]
16. [Determination of blood polyamines in patients with brain tumor -with special reference to relationship between varieties of tumors and concentrations of blood spermidine and spermine (author's transl)].
Terabayashi T; Tanimura K; Ueki K
No Shinkei Geka; 1976 Nov; 4(11):1051-6. PubMed ID: 1034226
[TBL] [Abstract][Full Text] [Related]
17. CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer.
Yap BS; Yap HY; Fritsche HA; Blumenschein G; Bodey GP
JAMA; 1980 Oct; 244(14):1601-3. PubMed ID: 7420663
[TBL] [Abstract][Full Text] [Related]
18. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
19. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis.
Klee GG; Tallman RD; Goellner JR; Yanagihara T
Mayo Clin Proc; 1986 Jan; 61(1):9-13. PubMed ID: 3510343
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]